Focus on cancer and cardiovascular disease, and seize a value of over CNY 1 trillion health insurance market.
E-Health Now (Chinese: 华美浩联) announced that it had completed a Series A++ round of financing worth tens of millions of CNY. This funding round was led by Borchid Capital (Chinese: 蜂巧资本) and followed by Tongji Fund (Chinese: 同济校友基金).
This is a new financing round after E-Health Now completed its Series A+ round in June.
With the gradual increase in the incidence rate of chronic diseases and the demand for medical digitalization promoted by COVID-19, the health management industry is developing fast. E-Health Now maintains a long-term and deep cooperation relationship with high-quality medical institutions at home and abroad. It integrates the user, medical institution and insurance institution to reduce costs and increase efficiency through digital technology and innovative products, thus helping patients to obtain better medical services.
This round of financing will be used for the research and development of digital health management services and health insurance products for cancer and cardiovascular diseases.
The company's CEO Ms. Xu introduced that according to their prediction, the market size of cancer and cardiovascular diseases insurance will reach CNY 1.3 trillion, and the market size of health insurance for chronic diseases, ophthalmology and dentistry are expected to reach CNY 100 billion, respectively.
E-Health Now covers overseas specialty drugs and develops early cancer screening products to reduce the compensation cost through patient management. The company also develops products for non-standard populations with lung and thyroid nodules and carries out effective health management solutions for high-risk populations.
E-Health Now cooperates with high-quality medical institutions globally to provide education, health assessment, video consultation, emergency green channel, multidisciplinary team consultation, post-hospital rehabilitation and whole life cycle project management.
Its competitors include Haid Health (Chinese: 海德健康) and E-Health Now has the ambition to become the next United Health Group in China.